Chi­na's CStone rais­es $285M in IPO; Ax­i­al rais­es $25M for mi­cro­bio­me work on Parkin­son's, autism

→ Tar­get­ing the ax­is be­tween the gut and the brain, mi­cro­bio­me start­up Ax­i­al has land­ed a $25 mil­lion B round as it looks to ad­vance pro­grams for Parkin­son’s dis­ease and autism. Sev­en­ture Part­ners, through its mi­cro­bio­me-fo­cused fund Health for Life Cap­i­tal, led the round along­side the Long­wood Fund, Do­main As­so­ciates, Her­itage Med­ical Sys­tems and “a group of high net worth in­di­vid­u­als based in South­ern Cal­i­for­nia.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.